| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,179 | 73,614,390 | 0.06% | 0.72% | 2.20% | 5.77% | 17.01% | 13.02% |
| Healthcare | HEALTHCARE | Sector | 1,168 | 6,985,044 | 1.17% | 4.61% | 7.39% | 13.57% | 19.27% | 7.19% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 600 | 3,574,436 | 1.42% | 6.50% | 10.81% | 20.53% | 30.54% | 19.30% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 285 | 1,564,176 | 1.95% | 7.76% | 18.03% | 34.08% | 35.80% | 22.87% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Obstetrics and Gynecology Biopharmaceuticals | OBSTETRICS | SubInd | 1 | 19 | 2.75% | 41.18% | 34.40% | 11.05% | 15.00% | 15.00% |
| Endocrinology and Metabolism Biopharmaceuticals | ENDOCRINOLOGY | SubInd | 31 | 1,078,174 | 2.62% | 9.17% | 22.30% | 40.78% | 41.15% | 31.44% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 285 | 1,564,176 | 1.95% | 7.76% | 18.03% | 34.08% | 35.80% | 22.87% |
| Ophthalmology Biopharmaceuticals | OPHTHALMOLOGY | SubInd | 19 | 85,552 | 1.06% | 5.78% | 15.80% | 15.39% | 16.89% | -9.76% |
| Urology Biopharmaceuticals | UROLOGY | SubInd | 11 | 8,956 | 2.38% | 12.00% | 13.65% | 39.51% | 47.91% | 33.61% |
| Musculoskeletal System Biopharmaceuticals | MUSCULOSKELETAL | SubInd | 3 | 170 | -2.75% | -3.51% | 12.25% | 40.67% | 47.50% | 58.06% |
| Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 22 | 22,734 | -0.06% | 4.50% | 11.11% | 45.82% | 62.99% | 34.60% |
| Hematology Biopharmaceuticals | HEMATOLOGY | SubInd | 13 | 37,772 | -0.17% | 4.78% | 11.08% | 26.45% | 50.14% | 1.39% |
| Immunology Biopharmaceuticals | IMMUNOLOGY | SubInd | 31 | 27,683 | 1.50% | 4.68% | 10.74% | 23.81% | 30.90% | 43.49% |
| Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 28 | 31,757 | -1.03% | 4.73% | 9.97% | 31.79% | 73.94% | 26.85% |
| Cardiovascular System Biopharmaceuticals | CARDIOVASCULAR | SubInd | 17 | 37,989 | 0.44% | 7.03% | 8.31% | 52.89% | 75.70% | 39.93% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 94 | 115,327 | -0.10% | 3.18% | 7.04% | 17.73% | 25.71% | 0.88% |
| Respiratory System Biopharmaceuticals | RESPIRATORY | SubInd | 15 | 118,043 | 1.08% | 4.42% | 6.21% | 12.01% | 1.70% | -5.18% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,204 | 97,233,754 | 0.06% | 0.86% | 3.19% | 6.50% | 16.40% | 15.52% |
* Colors indicate performance relative to the benchmark.